日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD93 blockade overcomes sunitinib resistance in pancreatic neuroendocrine tumors.

CD93阻断可克服胰腺神经内分泌肿瘤的舒尼替尼耐药性

Sun Yi, Fujiwara Yuki, Torphy Robert J, Yee Elliott J, Guo Yujie, Sun Zhiwei, Hu Junyi, Eck Eleanor, Terai Taichi, Schulick Richard D, Zhu Yuwen

Influence of biologic sex and obesity on liver recurrence and survival in patients undergoing upfront surgery for pancreatic adenocarcinoma

生物性别和肥胖对接受胰腺腺癌根治性手术患者的肝脏复发和生存率的影响

Judge, Sean J; Manin, Emily; Chou, Joanne; Torphy, Robert J; McIntyre, Caitlin A; Balachandran, Vinod P; D'Angelica, Michael I; Drebin, Jeffrey A; Gönen, Mithat; Jarnagin, William R; Kingham, T Peter; O'Reilly, Eileen M; Park, Wungki; Wei, Alice C; Zervoudakis, Alice; Soares, Kevin C

GPR182 is a lipoprotein receptor for dietary fat absorption

GPR182是膳食脂肪吸收的脂蛋白受体

Sun, Zhiwei; Torphy, Robert J; Miller, Emily N; Darehshouri, Anza; Vigil, Isaac; Terai, Taichi; Eck, Eleanor; Sun, Yi; Guo, Yujie; Yee, Elliott J; Hu, Junyi; Kedl, Ross M; Lasda, Erika L; Hesselberth, Jay R; MacLean, Paul; Bruce, Kimberley D; Randolph, Gwendalyn J; Schulick, Richard D; Zhu, Yuwen

Group XIV C-type lectins: emerging targets in tumor angiogenesis

第十四组C型凝集素:肿瘤血管生成的新兴靶点

Yee, Elliott J; Vigil, Isaac; Sun, Yi; Torphy, Robert J; Schulick, Richard D; Zhu, Yuwen

Atypical chemokine receptors: emerging therapeutic targets in cancer

非典型趋化因子受体:癌症治疗的新兴靶点

Torphy, Robert J; Yee, Elliott J; Schulick, Richard D; Zhu, Yuwen

Circulating CD8(+) mucosal-associated invariant T cells correlate with improved treatment responses and overall survival in anti-PD-1-treated melanoma patients

循环CD8(+)黏膜相关不变T细胞与接受抗PD-1治疗的黑色素瘤患者的治疗反应改善和总生存期延长相关

Vorwald, Victoria M; Davis, Dana M; Van Gulick, Robert J; Torphy, Robert J; Borgers, Jessica Sw; Klarquist, Jared; Couts, Kasey L; Amato, Carol M; Cogswell, Dasha T; Fujita, Mayumi; Castleman, Moriah J; Davis, Timothy; Lozupone, Catherine; Medina, Theresa M; Robinson, William A; Gapin, Laurent; McCarter, Martin D; Tobin, Richard P

Induction Chemotherapy Plus Neoadjuvant Chemoradiation for Esophageal and Gastroesophageal Junction Adenocarcinoma

食管和胃食管交界处腺癌的诱导化疗联合新辅助放化疗

Ho, Felix; Torphy, Robert J; Friedman, Chloe; Leong, Stephen; Kim, Sunnie; Wani, Sachin; Schefter, Tracey; Scott, Christopher D; Mitchell, John D; Weyant, Michael J; Meguid, Robert A; Gleisner, Ana L; Goodman, Karyn A; McCarter, Martin D

Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix

胰腺导管腺癌的进展受间质基质的抑制。

Jiang, Honglin; Torphy, Robert J; Steiger, Katja; Hongo, Henry; Ritchie, Alexa J; Kriegsmann, Mark; Horst, David; Umetsu, Sarah E; Joseph, Nancy M; McGregor, Kimberly; Pishvaian, Michael J; Blais, Edik M; Lu, Brian; Li, Mingyu; Hollingsworth, Michael; Stashko, Connor; Volmar, Keith; Yeh, Jen Jen; Weaver, Valerie M; Wang, Zhen J; Tempero, Margaret A; Weichert, Wilko; Collisson, Eric A

Pancreatic cancer treatment: better, but a long way to go

胰腺癌治疗:有所改善,但仍有很长的路要走

Torphy, Robert J; Fujiwara, Yuki; Schulick, Richard D

High-Dimensional Analysis of Postsplenectomy Peripheral Immune Cell Changes

脾切除术后外周免疫细胞变化的高维分析

Borgers, Jessica S W; Tobin, Richard P; Vorwald, Victoria M; Smith, Joshua M; Davis, Dana M; Kimball, Abigail K; Clambey, Eric T; Couts, Kasey L; McWilliams, Jennifer A; Jordan, Kimberly R; Torphy, Robert J; Schulick, Richard; McCarter, Martin D